Lead party: LeapFrog Investments (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Good Life Pharmacy Limited (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Uganda, Kenya
Transaction type: Investment, Exit · Asset class: Private Equity · Strategy: Buyout · Instrument: Equity · Deal amount: US$22m · Fund: Catalyst Fund I
Lead investor/buyer: LeapFrog Investments · Investors/buyers: LeapFrog Investments, Ascension Investment Management, The Louis Family, PG Impact · Sellers: Catalyst Principal Partners
Legal advisers: not identified in the source record.
Source: announced 23 November 2016. Original announcement: globalprivatecapital.org.


